Upstream Bio (UPB) Total Liabilities (2023 - 2026)

Upstream Bio's Total Liabilities history runs 4 years deep, the most recent figure standing at $14.1 million for Q1 2026.

• On a quarterly basis, Total Liabilities rose 33.15% year-over-year to $14.1 million in Q1 2026; TTM through Mar 2026 was $14.1 million, a 33.15% increase from a year earlier, with the FY2025 full-year figure at $14.0 million, up 17.98% from the prior year.
• Total Liabilities held at $14.1 million in Q1 2026 per UPB's latest filing, from $14.0 million in the prior quarter.
• Across five years, Total Liabilities topped out at $14.1 million in Q1 2026 and bottomed at $9.4 million in Q4 2023.
• The 4-year median for Total Liabilities is $12.0 million (2024), against an average of $12.1 million.
• Across the five-year window, Total Liabilities gained 3.91% in 2025 and soared 33.15% in 2026, its largest moves.
• Year by year, Total Liabilities stood at $9.4 million in 2023, then rose by 26.39% to $11.9 million in 2024, then rose by 17.98% to $14.0 million in 2025, then climbed by 0.41% to $14.1 million in 2026.
• Per Business Quant, the three latest UPB Total Liabilities figures stand at $14.1 million (Q1 2026), $14.0 million (Q4 2025), and $12.6 million (Q3 2025).